{
  "ticker": "EMR",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02967906",
  "id": "02967906",
  "pages": 8,
  "price_sensitive": false,
  "date": "20250709",
  "time": "1825",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250709/pdf/06ln7fbyryvxlm.pdf",
  "summary": "### **Material Information Summary**  \n- **Securities Issued from Options Conversion**:  \n  - **1,275,000 new ordinary shares (EMR)** issued via options exercise on 09/07/2025.  \n    - **175,000 shares** at **A$1.09** (from EMRAK options).  \n    - **1,100,000 shares** at **A$0.67** (from EMRAE options), including **1,000,000 by KMP Michael Evans**.  \n  - **Remaining Options Outstanding**:  \n    - EMRAE (A$0.67 strike): **925,000**.  \n    - EMRAK (A$1.09 strike): **2,137,500**.  \n- **Post-Issue Capital Structure**:  \n  - **Total ordinary shares (EMR)**: **658,865,123** (quoted).  \n  - **Unquoted options**: Multiple tranches (see Part 4.2 for details).  \n\n**No material liquidity or valuation impact noted; standard options conversion.**  \n\n(Note: If further prioritization is needed, focus on the KMP-linked exercise and total dilution.)",
  "usage": {
    "prompt_tokens": 2743,
    "completion_tokens": 250,
    "total_tokens": 2993,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-09T08:35:20.633072"
}